Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669534 · ClinicalTrials.gov registry record · Phase 4
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
A Phase 4 study of HIV and Opioid Use Disorder, sponsored by University of Connecticut.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT05669534: Recruiting Phase 4 study of HIV and Opioid Use Disorder, sponsored by University of Connecticut.
NCT05669534 is a Phase 4 study of HIV and Opioid Use Disorder that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 256 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05669534, a Phase 4 study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enhancing the ability of PWID on MOUD to process and utilize HIV prevention content, leading to improvements in HIV prevention information, motivation, behavioral skills, and behaviors (IMB).
Primary Outcome
Dried Blood Spots will test the amount of active PrEP components in the participants blood.
Conditions Studied
Interventions
- BEHAVIORAL community-friendly health recovery program
- DRUG Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Study Locations (1)
Connecticut
- APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 4 |
What NCT05669534 shows while recruiting
NCT05669534 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which community-friendly health recovery program is the first listed.
NCT05669534 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05669534 about?
NCT05669534 is a clinical study titled "Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP". The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enha...
What is the current status of trial NCT05669534?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 256 participants. The study started on 2023-03-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05669534 study?
This clinical trial studies the following conditions: HIV, Opioid Use Disorder.
What interventions are being tested in trial NCT05669534?
The interventions under investigation include: community-friendly health recovery program (BEHAVIORAL), Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis (DRUG).
Who is sponsoring clinical trial NCT05669534?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669534 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05669534's enrollment target sits among peer trials
256 81st of 303 higher than 219 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
RECRUITING · Phase 4
-
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
RECRUITING · Phase 4
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
RECRUITING · Phase 4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
ACTIVE NOT RECRUITING · Phase 4
-
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI